Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals
NBER Working Paper No. 20927
---- Acknowledgements ----
This study was funded in part by a grant from the National Institute of Aging (NIA) and the NIH Common Fund for Health Economics (Grant R01-AG043850) and a grant from the California Health Care Foundation. The authors thank Teague Ruder for programming support and seminar participants at the American Society of Health Economics biennial meetings, the International Health Economics Association annual meetings, RAND, the University of Southern California, the University of Minnesota, Vanderbilt University, Emory University, and McGill University. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.